Luther King Capital Management (LKCM)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55M Sell
32,557
-20,637
-39% -$1.66M 0.01% 337
2026
Q1
$4.61M Sell
53,194
-8,676
-14% -$831K 0.02% 262
2025
Q4
$5.94M Buy
61,870
+29,968
+94% +$2.91M 0.02% 236
2025
Q3
$3.04M Sell
31,902
-925
-3% -$85K 0.01% 300
2025
Q2
$2.86M Sell
32,827
-737
-2% -$62.5K 0.01% 297
2025
Q1
$3.02M Sell
33,564
-4,106
-11% -$367K 0.01% 276
2024
Q4
$3.01M Sell
37,670
-3,610
-9% -$313K 0.01% 286
2024
Q3
$3.72M Sell
41,280
-14,464
-26% -$1.22M 0.02% 263
2024
Q2
$4.39M Sell
55,744
-40,556
-42% -$3.32M 0.02% 231
2024
Q1
$8.39M Buy
96,300
+3,564
+4% +$304K 0.04% 168
2023
Q4
$7.64M Sell
92,736
-34,237
-27% -$2.61M 0.04% 169
2023
Q3
$9.95M Sell
126,973
-25,661
-17% -$2.15M 0.05% 147
2023
Q2
$13.4M Sell
152,634
-1,550
-1% -$133K 0.07% 133
2023
Q1
$12.4M Sell
154,184
-2,034
-1% -$166K 0.07% 135
2022
Q4
$12.1M Sell
156,218
-35,553
-19% -$2.88M 0.07% 134
2022
Q3
$15.5M Sell
191,771
-17,128
-8% -$1.54M 0.09% 122
2022
Q2
$18.7M Sell
208,899
-14,536
-7% -$1.47M 0.1% 119
2022
Q1
$24.8M Sell
223,435
-27,594
-11% -$2.92M 0.12% 117
2021
Q4
$26M Buy
251,029
+1,416
+0.6% +$164K 0.12% 114
2021
Q3
$31.3M Sell
249,613
-3,372
-1% -$436K 0.15% 105
2021
Q2
$31.4M Sell
252,985
-14,684
-5% -$1.84M 0.15% 105
2021
Q1
$31.6M Sell
267,669
-13,113
-5% -$1.54M 0.17% 104
2020
Q4
$32.9M Sell
280,782
-8,813
-3% -$970K 0.19% 96
2020
Q3
$30.1M Sell
289,595
-9,240
-3% -$928K 0.19% 91
2020
Q2
$27.4M Sell
298,835
-12,739
-4% -$1.22M 0.19% 95
2020
Q1
$28.1M Sell
311,574
-8,567
-3% -$911K 0.24% 83
2019
Q4
$36.3M Sell
320,141
-3,600
-1% -$395K 0.24% 82
2019
Q3
$35.2M Buy
323,741
+6,314
+2% +$659K 0.26% 81
2019
Q2
$30.9M Sell
317,427
-1,292
-0.4% -$118K 0.23% 86
2019
Q1
$29M Sell
318,719
-22,022
-6% -$1.97M 0.22% 89
2018
Q4
$31M Sell
340,741
-2,992
-0.9% -$280K 0.28% 82
2018
Q3
$33.8M Sell
343,733
-9,520
-3% -$880K 0.26% 85
2018
Q2
$30.2M Sell
353,253
-325,018
-48% -$27.1M 0.25% 84
2018
Q1
$54.4M Sell
678,271
-253,861
-27% -$20.9M 0.46% 64
2017
Q4
$75.3M Sell
932,132
-724,955
-44% -$58.1M 0.62% 57
2017
Q3
$129M Buy
1,657,087
+1,960
+0.1% +$163K 1.13% 31
2017
Q2
$147M Sell
1,655,127
-26,942
-2% -$2.27M 1.33% 25
2017
Q1
$136M Sell
1,682,069
-38,603
-2% -$3.02M 1.25% 25
2016
Q4
$123M Sell
1,720,672
-93,015
-5% -$7.31M 1.17% 26
2016
Q3
$157M Buy
1,813,687
+43,847
+2% +$3.82M 1.53% 11
2016
Q2
$154M Buy
1,769,840
+178,618
+11% +$14.4M 1.5% 11
2016
Q1
$119M Buy
1,591,222
+45,094
+3% +$3.4M 1.19% 24
2015
Q4
$119M Sell
1,546,128
-80,655
-5% -$6.07M 1.12% 24
2015
Q3
$109M Buy
1,626,783
+456,139
+39% +$33.6M 1.06% 27
2015
Q2
$86.7M Buy
1,170,644
+357,520
+44% +$27.3M 0.75% 47
2015
Q1
$63.4M Buy
813,124
+783,288
+2,625% +$59.4M 0.53% 60
2014
Q4
$2.15M Sell
29,836
-1,700
-5% -$118K 0.02% 308
2014
Q3
$1.95M Sell
31,536
-1,300
-4% -$82.7K 0.02% 323
2014
Q2
$2.09M Sell
32,836
-3,775
-10% -$229K 0.02% 316
2014
Q1
$2.25M Sell
36,611
-4,885
-12% -$285K 0.02% 317
2013
Q4
$2.38M Sell
41,496
-90
-0.2% -$5.1K 0.02% 328
2013
Q3
$2.21M Buy
41,586
+2,900
+7% +$156K 0.02% 332
2013
Q2
$1.99M Buy
+38,686
New +$1.91M 0.02% 335

Other funds holding MDT

Luther King Capital Management (LKCM)'s MDT Position: Q2 2026 in Review

Luther King Capital Management (LKCM) reduced its Medtronic (MDT) stake by 39% in Q2 2026, selling an estimated $1.66M and leaving 32,557 shares worth $2.55M. The position accounts for 0.01% of the portfolio, ranked #337.

Luther King Capital Management (LKCM) first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $157M in Q3 2016. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Luther King Capital Management (LKCM) held 32,557 shares of Medtronic worth $2.55M as of Q2 2026.
  • Luther King Capital Management (LKCM) sold 20,637 Medtronic shares in Q2 2026, an estimated $1.66M.
  • Medtronic made up 0.01% of Luther King Capital Management (LKCM)'s portfolio in Q2 2026, its #337 holding.
  • Luther King Capital Management (LKCM) first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Luther King Capital Management (LKCM)'s Medtronic position peaked at $157M in Q3 2016.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2026, filed 10 Aug 2026.